[HTML][HTML] Necroptosis Induced by Delta-Tocotrienol Overcomes Docetaxel Chemoresistance in Prostate Cancer Cells
M Montagnani Marelli, G Beretta… - International Journal of …, 2023 - mdpi.com
Prostate cancer (PCa) represents the fifth cause of cancer death in men. Currently,
chemotherapeutic agents for the treatment of cancers, including PCa, mainly inhibit tumor …
chemotherapeutic agents for the treatment of cancers, including PCa, mainly inhibit tumor …
Necroptosis Induced by Delta-Tocotrienol Overcomes Docetaxel Chemoresistance in Prostate Cancer Cells.
M Montagnani Marelli, G Beretta… - International Journal of …, 2023 - search.ebscohost.com
Prostate cancer (PCa) represents the fifth cause of cancer death in men. Currently,
chemotherapeutic agents for the treatment of cancers, including PCa, mainly inhibit tumor …
chemotherapeutic agents for the treatment of cancers, including PCa, mainly inhibit tumor …
Necroptosis Induced by Delta-Tocotrienol Overcomes Docetaxel Chemoresistance in Prostate Cancer Cells
MM Marelli, G Beretta… - International Journal of …, 2023 - search.proquest.com
Prostate cancer (PCa) represents the fifth cause of cancer death in men. Currently,
chemotherapeutic agents for the treatment of cancers, including PCa, mainly inhibit tumor …
chemotherapeutic agents for the treatment of cancers, including PCa, mainly inhibit tumor …
[HTML][HTML] Necroptosis Induced by Delta-Tocotrienol Overcomes Docetaxel Chemoresistance in Prostate Cancer Cells
MM Marelli, G Beretta, RM Moretti - International Journal of …, 2023 - ncbi.nlm.nih.gov
Prostate cancer (PCa) represents the fifth cause of cancer death in men. Currently,
chemotherapeutic agents for the treatment of cancers, including PCa, mainly inhibit tumor …
chemotherapeutic agents for the treatment of cancers, including PCa, mainly inhibit tumor …
Necroptosis Induced by Delta-Tocotrienol Overcomes Docetaxel Chemoresistance in Prostate Cancer Cells
G Beretta, R Moretti - International Journal of Molecular Sciences, 2023 - europepmc.org
Prostate cancer (PCa) represents the fifth cause of cancer death in men. Currently,
chemotherapeutic agents for the treatment of cancers, including PCa, mainly inhibit tumor …
chemotherapeutic agents for the treatment of cancers, including PCa, mainly inhibit tumor …
Necroptosis Induced by Delta-Tocotrienol Overcomes Docetaxel Chemoresistance in Prostate Cancer Cells
MM Marelli, G Beretta… - International journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Prostate cancer (PCa) represents the fifth cause of cancer death in men. Currently,
chemotherapeutic agents for the treatment of cancers, including PCa, mainly inhibit tumor …
chemotherapeutic agents for the treatment of cancers, including PCa, mainly inhibit tumor …
Necroptosis Induced by Delta-Tocotrienol Overcomes Docetaxel Chemoresistance in Prostate Cancer Cells
M Montagnani Marelli, G Beretta… - INTERNATIONAL …, 2023 - air.unimi.it
Prostate cancer (PCa) represents the fifth cause of cancer death in men. Currently,
chemother-apeutic agents for the treatment of cancers, including PCa, mainly inhibit tumor …
chemother-apeutic agents for the treatment of cancers, including PCa, mainly inhibit tumor …
[PDF][PDF] Necroptosis Induced by Delta-Tocotrienol Overcomes Docetaxel Chemoresistance in Prostate Cancer Cells
M Montagnani Marelli, G Beretta, RM Moretti - Int. J. Mol. Sci, 2023 - air.unimi.it
Prostate cancer (PCa) represents the fifth cause of cancer death in men. Currently,
chemotherapeutic agents for the treatment of cancers, including PCa, mainly inhibit tumor …
chemotherapeutic agents for the treatment of cancers, including PCa, mainly inhibit tumor …
Necroptosis Induced by Delta-Tocotrienol Overcomes Docetaxel Chemoresistance in Prostate Cancer Cells.
G Beretta, RM Moretti - International Journal of Molecular …, 2023 - europepmc.org
Prostate cancer (PCa) represents the fifth cause of cancer death in men. Currently,
chemotherapeutic agents for the treatment of cancers, including PCa, mainly inhibit tumor …
chemotherapeutic agents for the treatment of cancers, including PCa, mainly inhibit tumor …